Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study

European Journal of Neurology 2025 Aug;32(8):e70328. doi: 10.1111/ene.70328. Stewart J Tepper, David W Dodick, Michel Lanteri-Minet , David Dolezil, Raquel Gil-Gouveia, Christian Lucas, Karolina Piasecka-Stryczynska, Gyöngyi Szabó, Daniel D Mikol, Mahan Chehrenama, Denise E Chou, Zilu Liu, Gabriel Paiva da Silva Lima  Abstract Background: Erenumab-induced medication overuse headache (MOH) remission in participants with

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny